| scholarly article | Q13442814 |
| P50 | author | Padinjaremattathil Thankappan Ullas | Q95005802 |
| P2093 | author name string | Anita Desai | |
| Shampur Narayan Madhusudana | |||
| P2860 | cites work | Toll-free vaccines? | Q79897713 |
| TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses | Q80427941 | ||
| Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice | Q84535799 | ||
| Pyogenic bacterial infections in humans with MyD88 deficiency | Q24653859 | ||
| The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 | ||
| Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets | Q30834266 | ||
| MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. | Q33392688 | ||
| Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments | Q33713435 | ||
| Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine | Q34521758 | ||
| Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity | Q34717036 | ||
| Rabies re-examined | Q34764816 | ||
| Cationic microparticles: A potent delivery system for DNA vaccines | Q34978592 | ||
| Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination | Q35826673 | ||
| Re-evaluating the burden of rabies in Africa and Asia. | Q36174024 | ||
| Gene-based vaccines: recent technical and clinical advances | Q36452337 | ||
| Targeting intracellular mediators of pattern-recognition receptor signalling to adjuvant vaccination. | Q37010299 | ||
| Nonviral vectors for gene delivery | Q37340494 | ||
| Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer | Q37548799 | ||
| Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles | Q37730793 | ||
| MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination | Q38725392 | ||
| Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge | Q39862726 | ||
| Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions | Q40364082 | ||
| Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers | Q40640587 | ||
| Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection | Q40920721 | ||
| Regulation of B1 cell migration by signals through Toll-like receptors | Q41974270 | ||
| Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids | Q42981116 | ||
| Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus | Q44415928 | ||
| Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection | Q44423451 | ||
| The effect of interferon-gamma on genetic immunization | Q44894186 | ||
| MyD88 is required for the formation of long-term humoral immunity to virus infection | Q45405612 | ||
| Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes | Q45752455 | ||
| Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen | Q45764135 | ||
| Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery. | Q45859155 | ||
| The history of Toll-like receptors - redefining innate immunity. | Q46240771 | ||
| TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses | Q46717065 | ||
| Super-activated interferon-regulatory factors can enhance plasmid immunization | Q56980983 | ||
| Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines | Q72641753 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rabies | Q39222 |
| rabies vaccine | Q4007169 | ||
| P304 | page(s) | 202-211 | |
| P577 | publication date | 2014-06-20 | |
| P1433 | published in | Clinical and Experimental Vaccine Research | Q26842097 |
| P1476 | title | Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant | |
| P478 | volume | 3 |
| Q47570996 | Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection |
| Q90384565 | Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies |
| Q37225198 | Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity |
| Q38342834 | Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases. |
Search more.